Categories: News

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Charlotte, North Carolina–(Newsfile Corp. – February 8, 2024) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation’s leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 13, 2024, to discuss the company’s December 31, 2023 first quarter of fiscal 2024 financial results and business progress.

CONFERENCE CALL DETAILS

Tuesday February 13, 2024, 4:20 p.m. Eastern Time
USA/Canada: 800-319-4610
International: 604-638-5340
Teleconference Replay dial in:
USA/Canada: 855-669-9658
International: 412-317-0088
Replay Passcode: 0714
Webcast/Webcast Replay link – available through February 13, 2025:
https://www.gowebcasting.com/13171

 

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company’s Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

1 THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.

Ronan Kennedy, Interim CEO and CFO

Phone: +1 (704) 445-3064 email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/197287

Staff

Recent Posts

RXST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that the…

33 minutes ago

Health-E Commerce® to Showcase flexible spending account (FSA) and health savings account (HSA) Engagement Tools at 38th Annual ECFC Symposium

FSA Store® and HSA Store® will demonstrate innovative e-commerce integrations, participant education resources, and compliance…

36 minutes ago

Telemedicine Market to Reach USD 393.5 Billion by 2032, Driven by 15.1% CAGR | SkyQuest Technology Consulting

The telemedicine market is anticipated to increase due to the rising incidence of chronic diseases…

36 minutes ago

Anywhere powered by Linus Health™ Expands Equitable Access to Early Detection of Cognitive Impairment

Fueled by successful community and clinical screenings, Linus Health brings its AI-powered remote cognitive assessment…

37 minutes ago

Siemens Healthineers Receives Frost & Sullivan’s 2025 North America Company of the Year Award for Excellence in Advanced Visualization Applications

Recognized for delivering diagnostic innovation, workflow efficiency, and enterprise imaging leadership through advanced visualization solutions…

37 minutes ago

AI Meets Brain Health: League and Linus Health Collaborate to Expand Health Plan Platforms

Bringing early detection of cognitive impairment to the forefront of health plan CX — empowering…

37 minutes ago